Tham khảo Steroid_đồng_hóa

  1. ↑ Kicman, A T (2008). “Pharmacology of anabolic steroids”. British Journal of Pharmacology 154 (3): 502–521. PMC 2439524. PMID 18500378. doi:10.1038/bjp.2008.165. 
  2. ↑ Powers M (2011). Houglum J, Harrelson GL, biên tập. Performance-Enhancing Drugs. Principles of Pharmacology for Athletic Trainers (ấn bản 2) (SLACK Incorporated). tr. 345. ISBN 978-1-55642-901-9. 
  3. ↑ Barrett-Connor EL (1995). “Testosterone and risk factors for cardiovascular disease in men”. Diabete Metab 21 (3): 156–61. PMID 7556805. 
  4. ↑ Yamamoto Y, Moore R, Hess HA, Guo GL, Gonzalez FJ, Korach KS, Maronpot RR, Negishi M (2006). “Estrogen receptor alpha mediates 17alpha-ethynylestradiol causing hepatotoxicity”. J Biol Chem 281 (24): 16625–31. PMID 16606610. doi:10.1074/jbc.M602723200. 
  5. ↑ De Piccoli B, Giada F, Benettin A, Sartori F, Piccolo E (1991). “Anabolic steroid use in body builders: an echocardiographic study of left ventricle morphology and function”. Int J Sports Med 12 (4): 408–12. PMID 1917226. doi:10.1055/s-2007-1024703. 
  6. 1 2 3 Green GA (tháng 9 năm 2009). “Performance-enhancing drug use”. Orthopedics 32 (9): 647–649. PMID 19751025. doi:10.3928/01477447-20090728-39. 
  7. 1 2 Turillazzi E, Perilli G, Di Paolo M, Neri M, Riezzo I, Fineschi V (2011). “Side effects of AAS abuse: an overview”. Mini Rev Med Chem 11 (5): 374–89. PMID 21443513. doi:10.2174/138955711795445925. 
  8. ↑ Hartgens F, Kuipers H (2004). “Effects of androgenic-anabolic steroids in athletes”. Sports Med 34 (8): 513–54. PMID 15248788. doi:10.2165/00007256-200434080-00003. 
  9. ↑ Kicman AT, Gower DB (tháng 7 năm 2003). “Anabolic steroids in sport: biochemical, clinical and analytical perspectives”. Ann. Clin. Biochem. 40 (Pt 4): 321–56. PMID 12880534. doi:10.1258/000456303766476977.